Vertex appoints e. morrey atkinson, ph.d.

Boston--(business wire)--vertex pharmaceuticals incorporated (nasdaq: vrtx) today announced that e. morrey atkinson, ph.d., has been appointed executive vice president, chief technical operations officer, head of biopharmaceutical sciences and manufacturing operations, effective immediately. dr. atkinson has served as senior vice president of global commercial manufacturing and supply chain since july 2020. this new role and function unifies responsibility for small molecule, cell and gene ther.
VRTX Ratings Summary
VRTX Quant Ranking